Evidence map›Paper›PMID 38807048›Full record

SynthesisBMC cardiovascular disorders2024

Inflammatory biomarkers in cardiac syndrome X: a systematic review and meta-analysis.

Yuexia Zhao, Arshin Ghaedi, Pouria Azami, Seyed Ali Nabipoorashrafi, Hamed Bazrafshan Drissi, Maryam Amin Dezfouli, Shirin Sarejloo, Brandon Lucke-Wold, John Cerillo, Monireh Khanzadeh and 2 more

Erratum issuedAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC cardiovascular disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yuexia ZhaoShandong Mental Health Center, Jinan, Shandong Province, China.
Arshin GhaediStudent Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Pouria AzamiCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Ali NabipoorashrafiEndocrinology and Metabolism Research Center (EMRC), School of Medicine, Vali-Asr Hospital, Tehran, Iran.
Hamed Bazrafshan DrissiCardiovascular Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam Amin DezfouliFaculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Shirin SarejlooNorthern Health, Melbourne, VIC, Australia.
Brandon Lucke-WoldDepartment of Neurosurgery, University of Florida, Gainesville, USA.
John CerilloNova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Tampa Bay Regional Campus, Gulf to Bay Blvd, Clearwater, FL, 3375, USA.
Monireh KhanzadehGeriatric & Gerontology Department, Medical School, Tehran University of medical and health sciences, Tehran, Iran.
Negar JafariDepartment of cardiovascular medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Jnegar94@gmail.com.
Shokoufeh KhanzadehTabriz University of Medical Sciences, Tabriz, Iran. Khshokufe7@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn the current systematic review and meta-analysis, we aim to analyze the existing literature to evaluate the role of inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), tumor necrosis factor-a (TNF-a), and interleukin-6 (IL-6) among individuals with cardiac syndrome X (CSX) compared to healthy controls.

methodsWe used PubMed, Web of Science, Scopus, Science Direct, and Embase to systematically search relevant publications published before April 2, 2023. We performed the meta-analysis using Stata 11.2 software (Stata Corp, College Station, TX). So, we used standardized mean difference (SMD) with a 95% confidence interval (CI) to compare the biomarker level between patients and healthy controls. The I

resultsOverall, 29 articles with 3480 participants (1855 with CSX and 1625 healthy controls) were included in the analysis. There was a significantly higher level of NLR (SMD = 0.85, 95%CI = 0.55-1.15, I

conclusionThe results of this study showed that CSX leads to a significant increase in inflammatory biomarkers, including NLR, CRP, IL-6, TNF-a, and PLR.

Indexed as

BiomarkersInflammation MediatorsMicrovascular AnginaNeutrophilsAdultAgedBlood PlateletsC-Reactive ProteinFemaleHumansInflammationInterleukin-6Lymphocyte CountLymphocytesMaleMiddle AgedBiomarkersC-Reactive ProteinIL6 protein, humanInflammation MediatorsInterleukin-6Tumor Necrosis Factor-alphaBiomarkerCardiac syndrome XInflammationMeta-analysis

Identifiers

PMID38807048
PMCPMC11134643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.